Gemcitabine-induced drop in platelet counts

A case report

O. Balaji, D. Amita, R. T. Sereen, P. Navin

Research output: Contribution to journalArticle

Abstract

Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

Original languageEnglish
Pages (from-to)17-18
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number5
DOIs
Publication statusPublished - 01-01-2017
Externally publishedYes

Fingerprint

gemcitabine
Platelet Count
Thrombocytopenia
Platinum Compounds
Drug Therapy
Carboplatin
Platinum
Ovarian Neoplasms
Cisplatin
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Balaji, O. ; Amita, D. ; Sereen, R. T. ; Navin, P. / Gemcitabine-induced drop in platelet counts : A case report. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 5. pp. 17-18.
@article{fa034e5d688743c193cb51ff608cb393,
title = "Gemcitabine-induced drop in platelet counts: A case report",
abstract = "Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.",
author = "O. Balaji and D. Amita and Sereen, {R. T.} and P. Navin",
year = "2017",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2017.v10i5.17297",
language = "English",
volume = "10",
pages = "17--18",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "5",

}

Gemcitabine-induced drop in platelet counts : A case report. / Balaji, O.; Amita, D.; Sereen, R. T.; Navin, P.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 5, 01.01.2017, p. 17-18.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gemcitabine-induced drop in platelet counts

T2 - A case report

AU - Balaji, O.

AU - Amita, D.

AU - Sereen, R. T.

AU - Navin, P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

AB - Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=85018745710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018745710&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i5.17297

DO - 10.22159/ajpcr.2017.v10i5.17297

M3 - Article

VL - 10

SP - 17

EP - 18

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 5

ER -